Amneal Pharmaceuticals (NASDAQ:AMRX) Stock Price Up 2.9%

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRXGet Rating) shares shot up 2.9% on Friday . The stock traded as high as $2.13 and last traded at $2.11. 11,274 shares traded hands during trading, a decline of 99% from the average session volume of 1,191,421 shares. The stock had previously closed at $2.05.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised shares of Amneal Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Friday, September 16th.

Amneal Pharmaceuticals Price Performance

The company has a current ratio of 1.56, a quick ratio of 1.03 and a debt-to-equity ratio of 15.38.

Amneal Pharmaceuticals Company Profile

(Get Rating)

Amneal Pharmaceuticals, Inc, together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories.

Further Reading

Receive News & Ratings for Amneal Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amneal Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.